8 results for "pharma"
Explore the debate on the future of cannabis medicine, whole-plant standards, and what pharmaceutical convergence means …
Read more →Federal cannabis rescheduling risks sidelining social equity operators and mirroring Big Pharma. Learn what this means f…
Read more →Opponents and a pharma firm file a brief to block a Trump-era plan providing Medicare coverage for hemp-derived CBD prod…
Read more →Federal appeals court rejects bid to block cannabis rescheduling, allowing the regulatory reform process to continue ami…
Read more →Federal marijuana rescheduling paves the way for M&A activity as pharma and ag firms eye the cannabis industry. What ope…
Read more →Pharma and drug testing firms sue to block cannabis rescheduling, citing public health concerns and potential delays for…
Read more →The DOJ is fighting industry attempts to block cannabis rescheduling, citing that opponents are protecting financial int…
Read more →Anti-marijuana groups and a pharma firm are appealing a ruling on Medicare's hemp product coverage program. Read the bus…
Read more →